Imaging Interactions

Introduction SensEye G CoViD-19 SARS-CoV-2 Variants MP5

After SensEye launched the first CoViD-19 SPR-sensor in May last year, SensEye now launches the first sensor to study the simultaneous antibody binding to the trimeric spike protein of SARS-CoV-2 variants of concern. Beside the spike protein of the wild type variant of the virus (Wuhan), the sensor includes the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1) variants. For ease of data interpretation, wild type S1 (RBD containing) protein has also been included on this SensEye.
Read more …

 

Make the difference between a successful program and a clinical failure